Emily Ko is an Oncology physician affiliated with University of Pennsylvania Health System. OpenAlex indexes 14 publications with 1,482 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis
American Journal of Obstetrics and Gynecology
2024 - Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
Frontiers in Cellular Neuroscience
2018 - Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome
Stem Cell Research & Therapy
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Jerome Strauss, MD, PhD
University of Pennsylvania Health System
Arthur Staddon, MD
University of Pennsylvania Health System
Keith Calligaro, MD
University of Pennsylvania Health System
Fiona Simpkins, MD
University of Pennsylvania Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”